Table 1.
Growth curve modeling results for the patients with diabetes
| Outcome | Pre-intervention Estimate, (95% CI) |
Post-intervention1 Estimate, (95% CI) |
1-Month F/U2 Estimate, (95% CI) |
Slope, (95% CI), P-value |
|---|---|---|---|---|
| HbA1c (%) | 8.1 (7.38, 8.89) | 7.9 (7.15, 8.55) | 7.7 (7.01, 8.44) | −0.028 (−0.059, 0.002) 0.0683 |
| BMI (kg/m2) | 35.10 (33.21, 36.98) | 34.88 (33.03, 36.74) | 34.79 (32.93, 36.64) | −0.021 (−0.045, 0.003) 0.0808 |
| Waist (cm) | 106.26 (102.65, 109.65) | 105.42 (101.96, 108.89) | 105.05 (101.58, 108.52) | −0.083 (−0.167, 0.001) 0.0516 |
| SBP (mmHg) | 133.82 (126.38, 141.25) | 126.98 (120.88, 133.07) | 123.90 (117.03, 130.77) | −0.684 (−1.210, −0.158) 0.0124 |
| DBP (mmHg) | 82.46 (78.52, 86.40) | 80.49 (77.49, 83.49) | 79.60 (76.28, 82.93) | −0.197 (−0.471, 0.077) 0.1536 |
| LDL (mg/dL) | 92.90 (82.67, 103.13) | 85.57 (75.98, 95.16) | 82.27 (70.76, 93.78) | −0.733 (−1.553, 0.087) 0.0788 |
| MET-min/week | 6,494.46 (4,579.69, 8,409.22) | 6,796.76 (4,788.15, 8,805.37) | 6,932.80 (4,310.24, 9,555.35) | 30.230 (−171.72, 232.18) 0.7618 |
| Kcal/week | 9,108.76 (6,411.07, 11,806) | 9,615.33 (6,611.31, 12,619) | 9,843.29 (5,954.07, 13,733) | 50.658 (−234.50, 335.82) 0.7187 |
| Diabetes Self-efficacy (α=.87) | 6.55 (5.92, 7.18) | 7.84 (7.43, 8.25) | 8.42 (7.98, 8.86) | 0.129 (0.084, 0.174) <0.0001 |
| DFBC nonsupportive (α=.64) | 19.27 (17.70, 20.84) | 20.69 (19.58, 21.80) | 21.33 (19.85, 22.800 | 0.142 (−0.010, 0.294) 0.0658 |
| DFBC Supportive (α=.70) | 25.64 (23.61, 27.67) | 27.33 (26.01, 28.65) | 28.09 (26.38, 29.80) | 0.169 (−0.015, 0.354) 0.0711 |
| SDSCA Diet (α=.50) | 2.32 (1.84, 2.80) | 4.93 (4.42, 5.44) | 4.58 (4.04, 5.11) | ≤10 weeks: 0.261 (0.186, 0.335) <0.0001 increment >10: −0.340 (−0.543, −0.137) 0.0019 |
| SDSCA General diet (α=.81) | 1.98 (1.37, 2.60) | 4.75 (4.03, 5.47) | 4.51 (3.89, 5.14) | ≤10 weeks: 0.277 (0.172, 0.381) <0.0001 increment >10: −0.329 (−0.604, −0.055) 0.0209 |
| SDSCA Specific diet (α=.32) | 3.59 (3.04, 4.14) | 4.42 (3.97, 4.87) | 4.79 (4.23, 5.35) | 0.083 (0.034, 0.132) 0.0016 |
| SDSCA Exercise (α=.66) | 2.05 (1.26, 2.83) | 2.10 (1.62, 2.57) | 2.12 (1.63, 2.62) | 0.005 (−0.048, 0.059) 0.8444 |
| SDSCA Blood (α=.94) | 1.29 (0.58, 1.99) | 1.12 (0.32, 1.92) | 2.32 (1.32, 3.31) | ≤10 weeks: −0.017 (−0.097, 0.064) 0.6776 increment >10: 0.282 (0.035, 0.530) 0.0265 |
| SDSCA foot | 4.21 (3.19, 5.24) | 6.63 (6.04, 7.22) | 5.91 (5.11, 6.71) | ≤10 weeks: 0.242 (0.125, 0.358) 0.0002 increment >10: −0.401 (−0.636, −0.165) 0.0016 |
| SDSCA smoke | 7.4% (2.0%, 24.1%) | 3.3% (0.8%, 12.0%) | 2.2% (0.3%, 13.2%) | −0.087 (−0.244, 0.071) 0.2763 |
| SDSCA meds | 6.14 (5.35, 6.92) | 6.08 (5.41, 6.74) | 6.05 (5.22, 6.87) | −0.006 (−0.075, 0.063) 0.8590 |
| SKILLD Score (KR-20=.65) | 4.07 (3.32, 4.82) | 9.08 (8.32, 9.85) | 8.62 (8.08, 9.17) | ≤10 weeks: 0.501 (0.389, 0.614) <0.0001 increment >10: −0.604 (−0.900, −0.307) 0.0003 |
| BRFSS item #1 | 3.38 (2.81, 3.95) | 3.59 (3.18, 4.00) | 3.68 (3.19, 4.17) | 0.021 (−0.026, 0.067) 0.3734 |
| BRFSS score (mean of reversed items 2–6) (α=.60) | 3.46 (3.18, 3.73) | 4.06 (3.87, 4.25) | 3.70 (3.44, 3.96) | ≤10 weeks: 0.060 (0.028, 0.092) 0.0006 increment >10: −0.140 (−0.227, −0.054) 0.0021 |
| PCS-12 (α=.70) | 61.53 (53.62, 69.45) | 69.42 (63.30, 75.54) | 72.96 (66.78, 79.15) | 0.788 (0.364, 1.213) 0.0006 |
| MCS-12 (α=.74) | 58.40 (52.41, 64.38) | 63.98 (59.51, 68.46) | 66.50 (61.45, 71.55) | 0.559 (0.123, 0.994) 0.0134 |
1
Mean time from pre- of all patients post-intervention was approximately 10 weeks
2
Mean time from pre- of all patients at 1-month follow-up was approximately 14.5 weeks